Tina Chang

Executive Assistant to GM
HippoScreen Neurotech
Tina studied Psychology at NTU and earned her M.S. in Counseling from SUNY-Albany. After working four years as a mental health counselor at Queens Hospital Center in New York, she decided to change career paths and obtained her MBA from CUNY-Baruch. Over the years, Tina has held positions at multinational companies like Colgate-Palmolive, where she worked in Finance and Customer Marketing capacities, as well as boutique consulting firms in Shanghai.
In 2015, Tina returned to Taiwan and began her Medtech career at GaleMed. Her vision is to empower Taiwanese Medtech startups with great potential to thrive on the global stage. During her five years at GiMer Medical, a Neuromodulation startup, Tina played a crucial role in bringing prototypes to the US and establishing a network of KOLs who provided valuable insights for product enhancement. She also enabled the company’s collaboration with Medtronic.
With her mental health background, Tina finds personal fulfillment in joining HippoScreen Neurotech to innovate and promote mental health through AI technology.
 

Speech title & Synopsis

Stress EEG Assessment System

HippoScreen Neurotech Corp. (HNC) was established in March 2019 by Compal Computer's direct investment in the research team of Professor Liu, Yi-Hung. The company's core competency lies in EEG signal processing and artificial intelligence technology, aiming to develop AI-assisted EEG tools for the diagnosis and evaluation in mental/brain disorder field.  
The Stress EEG Assessment (SEA) system was developed to assist the diagnosis of Depression. The system includes an EEG amplifier for data collection and signal processing, a GUI for test process control, and an AI algorithm for data analysis. 

The AI model for SEA was built using EEG data collected through collaboration with three major medical centers in Taiwan, with a sample size of 400+ people. It has a sensitivity of 88% and specificity of 80% in detection of Depression. The research result has been published in Biosensors.
The test takes 15-20 minutes to complete and can be administered by layperson trained by the company. The assessment report, which provides objective and quantifiable SEA Index and intuitive data distribution maps, is generated in real time. 
More than 20 hospitals and clinics in Taiwan have implemented SEA system in clinical practices. Physicians commend the objective system for its usefulness to enhance patient insight, leading to improved treatment adherence. 
To broaden its positive impact, HippoScreen aims to extend the use of SEA beyond hospitals to corporations and communities. By conducting brief brainwave assessments, we help at-risk populations increase their awareness of the disease, promote early diagnosis and treatment, and strengthen the overall health and well-being of society.